GEORGE E. DEESE - 11 Mar 2021 Form 4 Insider Report for FLOWERS FOODS INC (FLO)

Role
Director, Non-Executive Chairman
Signature
/s/ Stephanie B. Tillman, Agent
Issuer symbol
FLO
Transactions as of
11 Mar 2021
Net transactions value
$0
Form type
4
Filing time
01 Jun 2021, 16:57:04 UTC
Next filing
11 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLO Common Stock Gift $0 -12,410 -0.61% $0.000000 2,034,380 11 Mar 2021 Direct F1
transaction FLO Common Stock Gift $0 +12,410 +4.7% $0.000000 275,978 11 Mar 2021 By Family Trusts F2
transaction FLO Common Stock Options Exercise $0 +5,700 +0.28% $0.000000 2,040,080 27 May 2021 Direct F1
holding FLO Common Stock 50,301 11 Mar 2021 By Spouse F3
holding FLO Common Stock 24,467 11 Mar 2021 By IRA
holding FLO Common Stock 675,000 11 Mar 2021 By Family LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLO Deferred Stock Award $0 +6,050 $0.000000 6,050 27 May 2021 Common Stock 6,050 Direct F5, F6, F7
transaction FLO Deferred Stock Options Exercise $0 -5,700 -100% $0.000000* 0 27 May 2021 Common Stock 5,700 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 61,396 shares held by a revocable trust, for which trust reporting person is the sole beneficiary and trustee.
F2 Shares held by multiple family trusts, for all of which trusts reporting person is a co-trustee.
F3 Beneficial ownership is disclaimed.
F4 Shares held by family LLC, in which reporting person and his spouse are the only voting members.
F5 Granted under the Flowers Foods, Inc. 2014 Omnibus Equity and Incentive Compensation Plan.
F6 In accordance with the terms of the Flowers Foods, Inc. Deferred Shares Agreement for Directors, the deferred shares awarded do not have a conversion or exercise price.
F7 No expiration date.